Sale!

DNAJB2 Gene Spinal Muscular Atrophy Type 5 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The DNAJB2 gene is closely associated with a form of spinal muscular atrophy (SMA) known as type 5. SMA type 5 is a rare genetic disorder characterized by progressive muscle weakness and atrophy, primarily affecting the motor neurons in the spinal cord. The DNAJB2 gene plays a crucial role in the maintenance and function of these neurons. Mutations in this gene can lead to the development of SMA type 5, making genetic testing for these mutations an important tool for diagnosis and family planning.

DNA Labs UAE offers a specialized genetic test for the DNAJB2 gene to help identify mutations that are associated with spinal muscular atrophy type 5. This test is crucial for individuals with a family history of SMA or those exhibiting symptoms related to motor neuron dysfunction. By analyzing the DNAJB2 gene, the test can confirm a diagnosis, allowing for early intervention and management strategies to be implemented. Additionally, it can provide essential information for families considering future pregnancies.

The cost of the DNAJB2 gene spinal muscular atrophy type 5 genetic test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to detect mutations in the DNAJB2 gene accurately. Given the complexity of genetic testing and the specific expertise required to interpret the results, the cost reflects both the technological and professional resources involved in providing accurate and actionable information for patients and their families.

Description

DNAJB2 Gene Spinal Muscular Atrophy Type 5 Genetic Test

Test Name: DNAJB2 Gene Spinal Muscular Atrophy Type 5 Genetic Test

Components: DNAJB2 gene analysis

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for DNAJB2 Gene Spinal Muscular Atrophy Type 5 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with DNAJB2 Gene Spinal Muscular Atrophy Type 5.

Test Details:

The DNAJB2 gene is associated with spinal muscular atrophy type 5 (SMA5), a rare genetic disorder characterized by muscle weakness and wasting. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously to identify genetic variations that may be associated with a particular condition. In the context of SMA5, NGS genetic testing can help identify variations or mutations in the DNAJB2 gene that may be causing the condition.

This information can be helpful for confirming a diagnosis, understanding the underlying genetic cause of the disease, and providing information for genetic counseling and family planning. NGS genetic testing involves sequencing the DNA of an individual using advanced technology to detect variations in specific genes associated with the condition. This can be done using a blood or saliva sample.

The results of the test can help guide treatment decisions and provide important information about the prognosis of the condition. It is important to note that genetic testing for SMA5 and other genetic disorders should be done under the guidance of a healthcare professional or genetic counselor, who can help interpret the results and provide appropriate support and guidance.

Test Name	DNAJB2 Gene Spinal muscular atrophy type 5 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Neurological Disorders
Doctor	Neurologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for DNAJB2 Gene Spinal muscular atrophy type 5 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with DNAJB2 Gene Spinal muscular atrophy type 5
Test Details	The DNAJB2 gene is associated with spinal muscular atrophy type 5 (SMA5), which is a rare genetic disorder characterized by muscle weakness and wasting. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously to identify genetic variations that may be associated with a particular condition. In the context of SMA5, NGS genetic testing can help identify variations or mutations in the DNAJB2 gene that may be causing the condition. This information can be helpful for confirming a diagnosis, understanding the underlying genetic cause of the disease, and providing information for genetic counseling and family planning. NGS genetic testing involves sequencing the DNA of an individual using advanced technology to detect variations in specific genes associated with the condition. This can be done using a blood or saliva sample. The results of the test can help guide treatment decisions and provide important information about the prognosis of the condition. It is important to note that genetic testing for SMA5 and other genetic disorders should be done under the guidance of a healthcare professional or genetic counselor, who can help interpret the results and provide appropriate support and guidance.